{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:15:05Z","timestamp":1783008905723,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoiotech.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immuno-Oncology and Technology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.iotech.2025.101062","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:09:51Z","timestamp":1749816591000},"page":"101062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Properties of CD8 T-cell-recognized neoantigens in different tumor types"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7178-1391","authenticated-orcid":false,"given":"S.L.C.","family":"Ketelaars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gangaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4942-5709","authenticated-orcid":false,"given":"N.","family":"van Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Patiwael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hoefakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5763-6726","authenticated-orcid":false,"given":"L.F.","family":"Fanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.N.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kvistborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-7704","authenticated-orcid":false,"given":"J.B.A.G.","family":"Haanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iotech.2025.101062_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"10.1016\/j.iotech.2025.101062_bib2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.2100700","article-title":"NeoScore integrates characteristics of the neoantigen: MHC class I interaction and expression to accurately prioritize immunogenic neoantigens","volume":"208","author":"Borden","year":"2022","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.iotech.2025.101062_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.iotech.2025.101062_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nri1250","article-title":"Making sense of mass destruction: quantitating MHC class I antigen presentation","volume":"3","author":"Yewdell","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.iotech.2025.101062_bib5","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/s41467-022-29342-0","article-title":"Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma","volume":"13","author":"Holm","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.iotech.2025.101062_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150535","article-title":"Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma","volume":"132","author":"Kristensen","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.iotech.2025.101062_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fimmu.2017.01566","article-title":"An analysis of natural T cell responses to predicted tumor neoepitopes","volume":"8","author":"Bjerregaard","year":"2017","journal-title":"Front Immunol"},{"issue":"7913","key":"10.1016\/j.iotech.2025.101062_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","article-title":"Neoantigen quality predicts immunoediting in survivors of pancreatic cancer","volume":"606","author":"\u0141uksza","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.iotech.2025.101062_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cels.2019.08.009","article-title":"Neoantigen dissimilarity to the self-proteome predicts immunogenicity and response to immune checkpoint blockade","volume":"9","author":"Richman","year":"2019","journal-title":"Cell Syst"},{"issue":"14","key":"10.1016\/j.iotech.2025.101062_bib10","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows\u2013Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.iotech.2025.101062_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.iotech.2025.101062_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","article-title":"SomaticSniper: identification of somatic point mutations in whole genome sequencing data","volume":"28","author":"Larson","year":"2012","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.iotech.2025.101062_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.iotech.2025.101062_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.iotech.2025.101062_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.iotech.2025.101062_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002412","article-title":"Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire","volume":"8","author":"Calis","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.iotech.2025.101062_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1816s87","article-title":"Generation of peptide MHC class I monomers and multimers through ligand exchange","author":"Toebes","year":"2009","journal-title":"Curr Protoc Immunol"},{"issue":"5","key":"10.1016\/j.iotech.2025.101062_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nprot.2012.037","article-title":"Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers","volume":"7","author":"Andersen","year":"2012","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.iotech.2025.101062_bib19","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/s41467-021-22811-y","article-title":"Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features","volume":"12","author":"Gangaev","year":"2021","journal-title":"Nat Commun"},{"issue":"W1","key":"10.1016\/j.iotech.2025.101062_bib20","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.iotech.2025.101062_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114325","article-title":"Gene and protein sequence features augment HLA class I ligand predictions","volume":"43","author":"Bresser","year":"2024","journal-title":"Cell Rep"},{"issue":"19","key":"10.1016\/j.iotech.2025.101062_bib22","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1016\/j.cell.2021.08.020","article-title":"Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors","volume":"184","author":"Burger","year":"2021","journal-title":"Cell"},{"issue":"7528","key":"10.1016\/j.iotech.2025.101062_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.iotech.2025.101062_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010249","article-title":"Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression","volume":"12","author":"Roerden","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.iotech.2025.101062_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.immuni.2006.09.005","article-title":"Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses","volume":"25","author":"Yewdell","year":"2006","journal-title":"Immunity"},{"issue":"7463","key":"10.1016\/j.iotech.2025.101062_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.iotech.2025.101062_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005328","article-title":"Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma","volume":"10","author":"Church","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"7549","key":"10.1016\/j.iotech.2025.101062_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.iotech.2025.101062_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.973986","article-title":"CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity","volume":"13","author":"Baumgaertner","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.iotech.2025.101062_bib30","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3389\/fimmu.2018.02987","article-title":"Regulation of effector and memory CD8 T cell differentiation by IL-2-A balancing act","volume":"9","author":"Kalia","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.iotech.2025.101062_bib31","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/s41467-022-29718-2","article-title":"T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling","volume":"13","author":"Chin","year":"2022","journal-title":"Nat Commun"}],"container-title":["Immuno-Oncology and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259001882500022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259001882500022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:20:24Z","timestamp":1762633224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259001882500022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"alternative-id":["S259001882500022X"],"URL":"https:\/\/doi.org\/10.1016\/j.iotech.2025.101062","relation":{},"ISSN":["2590-0188"],"issn-type":[{"value":"2590-0188","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Properties of CD8 T-cell-recognized neoantigens in different tumor types","name":"articletitle","label":"Article Title"},{"value":"Immuno-Oncology and Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iotech.2025.101062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101062"}}